Kardigan to Participate in the Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan®, Inc. (Nasdaq: KARD), a precision cardiovascular company, today announced that the Company will participate in a fireside chat at the 2026 Jefferies London Healthcare Conference on Wednesday, November 18 at 4:30 PM (GMT). A live webcast of the fireside chat may be accessed via the Investors & Media section of the Kardigan website at https://ir.kardigan.bio/. Following the event, a replay of the presentations will be available on the website for a limited time.

About Kardigan

Kardigan is a clinical-stage precision cardiovascular company developing medicines that target the root cause of diseases where no approved treatments exist. Led by a proven and experienced management team, Kardigan is reimagining cardiovascular drug discovery and development through an integrated approach that unites deep cardiovascular biology, real-world patient data, and advanced analytics to enable more precise, efficient, and informed development of novel therapies. Learn more about Kardigan and its mission at Kardigan.bio.